Years of debate and deliberation over the widening of Bozeman Road will end Wednesday as construction begins on a large ...

Radiopharm Theranostics Ltd (ASX:RAD) has received approval from the Australian Ethics Committee to expand its trial to ...

Intellia's Phase 3 trial for NTLA-2002 shows promise, but limitations warrant caution. See why we believe NTLA stock is hold ...

German food delivery service Delivery Hero said the initial public offering (IPO) of its Middle East business Talabat is expected to raise around 1.42 billion euros ( $1.4 billion to $1.5 billion) in ...

Related ArticleStray Kids set to drop ‘HOP’ edition of ‘Skzhop Hiptape’ this DecemberStray Kids perform NSYNC-inspired ...

A trial evaluating the tamibarotene-Vidaza combination in certain patients with newly diagnosed high-risk MDS will be ...

Fate Therapeutics (FATE) presented initial clinical and translational data from the company’s Phase 1 study of FT522 in relapsed / refractory ...

A contract with ISG, a Sioux Falls, South Dakota, design and engineering firm, for the design and construction phase services of a city rail extension in the ...

The SPEAR 3, a precision-guided standoff munition that the U.K. Ministry of Defense describes as the “cruise missile of the ...

Regenxbio’s investigational gene therapy improved muscle function for patients with Duchenne muscular dystrophy (DMD) in a phase 1/2 study. | Regenxbio’s investigational gene therapy improved muscle ...

In this potentially valuable computational study, the authors conducted atomistic and coarse-grained simulations to probe the temperature-dependent phase behaviors of ELF3, a disordered component of ...

CART-007, an anti-CD7 CAR T-cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia or T-cell lymphoblastic ...